LAMP2A Liquid-Liquid Phase Separation Defects in Dopaminergic Neurons Create Selective Vulnerability to SNCA-Mediated CMA Blockade
🧪 Overview
LAMP2A exists in the lysosomal membrane as both monomers and higher-order oligomers that undergo liquid-liquid phase separation (LLPS) to form membrane microdomains essential for SNCA recognition and translocation into the lysosomal lumen. Recent biophysical studies demonstrate that LAMP2A's cytosolic tail contains an intrinsically disordered region capable of mediating homotypic LLPS, creating lipid-raft-like microdomains enriched in chaperone-HSC70. In A9 dopaminergic neurons (vulnerable), LAMP2A undergoes age-dependent oxidation at cysteine residues (particularly Cysteine 50), which disrupts LLPS and reduces the formation of functional CMA translocation microdomains. This oxidation occurs at higher rates in these neurons due to their elevated cytosolic dopamine oxidation and mitochondrial ROS production. The phase-separated LAMP2A domains normally concentrate SNCA for unfolding and import; when these domains disassemble, SNCA instead accumulates at the lysosomal membrane surface where it forms toxic oligomers. The prediction is that cysteine-to-serine LAMP2A mutants resistant to oxidation will rescue CMA function in dopaminergic neurons.
...🧬 Mechanism
Curated pathway from expert analysis
flowchart TD
A["LAMP2A Cytosolic Tail<br/>CMA Substrate Receptor"]
B["LAMP2A Oligomer Microdomains<br/>LLPS Assisted Assembly"]
C["HSC70 SNCA Recognition<br/>Chaperone Mediated Autophagy"]
D["SNCA Translocation into Lysosome<br/>Proteolytic Clearance"]
E["Dopaminergic Neuron LAMP2A Defect<br/>Microdomain Instability"]
F["SNCA CMA Blockade<br/>Toxic Oligomer Retention"]
G["Selective A9 Vulnerability<br/>Parkinsonian Degeneration"]
A --> B
B --> C
C --> D
E -.->|"destabilizes"| B
E --> F
F --> G
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — LAMP2
No curated PDB or AlphaFold mapping for LAMP2 yet. Search RCSB →
💉 Clinical Trials (1)
Active
Completed
Total Enrolled
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for LAMP2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF LAMP2A C50S oxidation-resistant mutant is expressed in aged human A9 dopaminergic neurons THEN chaperone-mediated autophagy flux will be restored to ≥60% of young neuron levels within 4 weeks, meas | CMA activity (lysosomal degradation of KFERQ-PAmCherry reporter) will be significantly higher in C50S-expressing aged A9 neurons compared to empty vector contro | — no observation — | pending | 0.78 |
| IF LAMP2A undergoes age-dependent oxidation at Cysteine 50 in A9 dopaminergic neurons THEN super-resolution microscopy will reveal ≥50% reduction in LAMP2A LLPS puncta density and puncta area, with ≥4 | STORM microscopy of substantia nigra neurons will show fewer and smaller LAMP2A phase-separated domains with age, colocalizing with increased SNCA oligomer sign | — no observation — | pending | 0.72 |
▸Metadata
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-28T11:41:20.404956'} |
| description | LAMP2A exists in the lysosomal membrane as both monomers and higher-order oligomers that undergo liquid-liquid phase separation (LLPS) to form membrane microdomains essential for SNCA recognition and |
| _schema_version | 1 |